Search Results - "Gordon, AN"

Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer by Gordon, Alan N., Tonda, Margaret, Sun, Steven, Rackoff, Wayne

“…Provide long-term follow-up data for women treated in a randomized multicenter study of pegylated liposomal doxorubicin compared with topotecan. Patients with…”
Get full text

Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan by GORDON, Alan N, FLEAGLE, John T, GUTHRIE, David, PARKIN, David E, GORE, Martin E, LACAVE, Angel J

“…To compare the efficacy and safety of pegylated liposomal doxorubicin (PLD) and topotecan in patients with epithelial ovarian carcinoma that recurred after or…”
Get full text

Efficacy and safety of erlotinib HCl, an epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor, in patients with advanced ovarian carcinoma: results from a phase II multicenter study by Gordon, A N, Finkler, N, Edwards, R P, Garcia, A A, Crozier, M, Irwin, D H, Barrett, E

“…The aim of this single-arm, phase II study was to estimate the tumor response rate and safety profile of erlotinib HCl (erlotinib, Tarceva, OSI-774)…”
Get more information

Phase II Study of Liposomal Doxorubicin in Platinum- and Paclitaxel-Refractory Epithelial Ovarian Cancer by GORDON, A. N, GRANAI, C. O, ROSE, P. G, HAINSWORTH, J, LOPEZ, A, WEISSMAN, C, ROSALES, R, SHARPINGTON, T

“…Stealth liposomal doxorubicin (Alzal Corp, Palo Alto, CA) has a slower clearance rate than free doxorubicin, resulting in sustained serum levels. Liposomal…”
Get full text

Systemic toxoplasmosis in captive flying-foxes by Sangster, CR, Gordon, AN, Hayes, D

“…Systemic toxoplasmosis caused by Toxoplasma gondii was diagnosed in two juvenile, captive flying‐foxes (Pteropus conspicillatus and P. scapulatus), which died…”
Get full text

Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis by Yuzhalin, Arseniy E., Lim, Su Yin, Kutikhin, Anton G., Gordon-Weeks, Alex N.

“…The main cause of cancer-related mortality, metastasis, is a complex, multi-step process. The extracellular matrix (ECM) component of solid tumors has been…”
Get full text

Role of pegylated liposomal doxorubicin in ovarian cancer by Thigpen, J. Tate, Aghajanian, Carol A., Alberts, David S., Campos, Susana M., Gordon, Alan N., Markman, Maurie, McMeekin, D. Scott, Monk, Bradley J., Rose, Peter G.

“…Safe, effective treatments are needed for relapsed ovarian cancer. Goals include improving symptoms, enhancing quality of life, and prolonging survival. The…”
Get full text

Validation of Referral Guidelines for Women With Pelvic Masses by Im, Samuel S., Gordon, Alan N., Buttin, Barbara M., Leath, Charles A., Gostout, Bobbie S., Shah, Chirag, Hatch, Kenneth D., Wang, Jianmin, Berman, Michael L.

“…OBJECTIVE:Guidelines for referring women with pelvic masses suspicious for ovarian cancers to gynecologic oncologists have been published jointly by Society of…”
Get full text

Liposomal anthracycline treatment for ovarian cancer by Markman, Maurie, Gordon, Alan N., McGuire, William P., Muggia, Franco M.

“…Platinum/taxane regimens induce high response rates and prolong survival in women with ovarian cancer. After recurrence, however, response to second-line…”
Get full text

A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer by Seiden, Michael V., Gordon, Alan N., Bodurka, Diane C., Matulonis, Ursula A., Penson, Richard T., Reed, Eddie, Alberts, Dave S., Weems, Garry, Cullen, Michael, McGuire, William P.

“…To determine the safety and efficacy of a novel illudin S derivative, irofulven (MGI-114), in patients with recurrent ovarian cancer who had received extensive…”
Get full text

A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma by CHAN, Stephen Y, GORDON, Alan N, COLEMAN, Robert E, HALL, James B, BERGER, Mark S, SHERMAN, Matthew L, ETEN, Catharine B, FINKLER, Neil J

“…The compound CMB-401 is an immunoconjugate consisting of the monoclonal antibody (MAb) hCTM01 directed against polymorphic epithelial mucin covalently bound to…”
Get full text

Alpaca plant poisonings: nitrate-nitrite and possible cyanide by McKenzie, R.A, Gordon, A.N, Burren, B.G, Gibson, J.A, Gardner, M.P

“…Nitrate–nitrite poisoning killed four adult alpacas and induced the abortion of a full‐term fetus after access to oaten hay (Avena sativa) containing 3.2% KNO3…”
Get full text

Lesions Caused by Cardiovascular Flukes (Digenea: Spirorchidae) in Stranded Green Turtles (Chelonia mydas) by Gordon, A. N., Kelly, W. R., Cribb, T. H.

“…Evidence of infection with spirorchid flukes (Digenea: Spirorchidae) was sought at necropsy of 96 stranded green turtles, Chelonia mydas, that were examined…”
Get full text

Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer by Gordon, Alan N, Asmar, Lina, Messing, Mark J, Street, Daron G, Pippitt, Charles H, Bailey, Cheryl L, Savage, John, Young, James A

“…Objective. Incorporating topotecan into standard platinum/taxane chemotherapy for advanced ovarian cancer has been complicated by myelosuppression. This study…”
Get full text

Adherence of trials of operative intervention to the CONSORT statement extension for non-pharmacological treatments: a comparative before and after study by Gray, R, Sullivan, M, Altman, D G, Gordon-Weeks, A N

“…Use of the Consolidated Standards of Reporting Trials (CONSORT) statement has been shown to improve the reporting of randomised controlled trials and it is…”
Get full text

Phase I Study of Alternating Doublets of Topotecan/Carboplatin and Paclitaxel/Carboplatin in Patients with Newly Diagnosed, Advanced Ovarian Cancer by Gordon, Alan N., Hancock, Kenneth C., Matthews, Carolyn M., Messing, Mark, Stringer, C.A., Doherty, Mark G., Teneriello, Michael

“…Objective. The aim of this study was to evaluate topotecan with carboplatin in an alternating doublet with carboplatin and paclitaxel in first-line ovarian…”
Get full text

Adherence of trials of operative intervention to the CONSORT statement by Carthy, E R, Agha, R, Gray, R, Sullivan, M, Altman, D G, Gordon-Weeks, A N

Get full text

Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting by Gordon, A N, Stringer, C A, Matthews, C M, Willis, D L, Nemunaitis, J

“…To determine the maximum-tolerable dose (MTD) of paclitaxel in a phase I dose-escalation study when combined with cisplatin in patients with advanced ovarian…”
Get more information

Depth of myometrial invasion in endometrial cancer: preoperative assessment by transvaginal ultrasonography by Gordon, A N, Fleischer, A C, Reed, G W

“…Twenty-five patients with cancer of the uterus underwent transvaginal sonography (TVS) to assess depth of myometrial invasion. All scans were performed with a…”
Get more information

Hapalotrema (Digenea: Spirorchidae) in the Green Turtle (Chelonia Mydas) in Australia by CRIBB, T. H, GORDON, A. N

“…Hapalotrema mehrai Rao, 1976 and Hapalotrema postorchis Rao, 1976 (Digenea: Spirorchidae) are redescribed from the heart and pulmonary arteries of the green…”
Get full text